Schott Pharma AG & CO KGaA Revenue Growth & History (1SXP)

Schott Pharma AG & CO KGaA reported €986.2M in revenue for fiscal 2025, an increase of 3.04% from the previous fiscal year.

View full Schott Pharma AG & CO KGaA company overview

Schott Pharma AG & CO KGaA annual revenue and growth

Schott Pharma AG & CO KGaA annual revenue

Fiscal yearPeriod endedRevenueChangeGrowth
20252025-09-30€986.2M€29.1M+3.04%
20242024-09-30€957.1M€58.5M+6.51%
20232023-09-30€898.6M€77.5M+9.43%
20222022-09-30€821.1M€172.5M+26.59%
20212021-09-30€648.7M€64.4M+11.03%
20202020-09-30€584.2M

Schott Pharma AG & CO KGaA revenue growth trends

Over the last five reported fiscal years, revenue grew from €584.2M to €986.2M, a compound annual growth rate of 11.04%. Schott Pharma AG & CO KGaA's latest reported quarter, Q3 2026, generated €281.8M in revenue, an increase of 9.99% year over year.

About the data

What revenue means

Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.

Financial data

Standardized company financials

TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.

Review Schott Pharma AG & CO KGaA source filings ↗

Community posts

It’s quiet here.

No posts about 1SXP yet. Start the conversation.

Write the first post